MeSH D008288 - malaria
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Chloroquine | Chloroquine | 1982-01-13 | |||
| Pyrimethamine | Pyrimethamine | 2021-08-13 | ||||
| Quinine | Quinine | 2012-09-28 | ||||
| Novast Laboratories | Primaquine | Primaquine | 2016-06-23 | |||
| Quinine | Quinine | 2015-07-22 | ||||
| Glenmark Pharmaceuticals | Atovaquone | Atovaquone | 2018-11-21 | |||
| Atovaquone, Proguanil | Atovaquone Proguanil | 2011-01-12 | ||||
| Mylan | Atovaquone, Proguanil | Atovaquone Proguanil | 2014-05-27 | |||
| GSK | Tafenoquine | Krintafel | 2018-07-20 | |||
| Atovaquone, Proguanil | Malarone | 2000-07-14 | ||||
| Atovaquone | Mepron | 1992-11-25 | ||||
| Roche | Pyrimethamine, Sulfadoxine | Fansidar | 1982-01-01 | |||
| Mefloquine | Lariam | 1989-05-02 | ||||
| Lupin Research | Atovaquone | Atovaquone | 2018-09-11 | |||
| Quinine | Quinine | 2015-04-24 | ||||
| Sandoz | Mefloquine | Mefloquine | 2002-02-20 | |||
| Novartis | Lumefantrine, Artemether | Coartem | 2009-04-07 |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
68%40/59
Phase 2
71%30/42
Phase 3
60%36/60
Approved: 15Overall Success rate: 29%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use